Global NGS-based RNA-seq Market Size, Status and Forecast 2021-2027

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

Market Analysis and Insights: Global NGS-based RNA-seq Market
The global NGS-based RNA-seq market size is projected to reach US$ 3013.7 million by 2026, from US$ 1409.2 million in 2019, at a CAGR of 11.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS-based RNA-seq market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS-based RNA-seq market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS-based RNA-seq market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS-based RNA-seq market.

Global NGS-based RNA-seq Scope and Market Size
NGS-based RNA-seq market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NGS-based RNA-seq market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
High-Throughput Sequencing
Third-Generation Sequencing Technology

Segment by Application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations

By Region
North America
Rest of Europe
South Korea
Southeast Asia
Rest of Asia
Latin America
Rest of Latin America
Middle East & Africa
Saudi Arabia
Rest of MEA

By Company
Thermo Fisher Scientific
Pacific Biosciences Of California
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Eurofins Scientific

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports